MOMENTA PHARMACEUTICALS INC·4

Feb 9, 4:52 PM ET

MOMENTA PHARMACEUTICALS INC 4

4 · MOMENTA PHARMACEUTICALS INC · Filed Feb 9, 2017

Insider Transaction Report

Form 4
Period: 2017-02-07
Ottmer Matthew P.
Chief Operating Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2017-02-07+48,00048,000 total
    Exercise: $18.85Exp: 2027-02-07Common Stock (48,000 underlying)
  • Award

    Restricted Stock Units

    2017-02-07+24,00024,000 total
    Common Stock (24,000 underlying)
Footnotes (3)
  • [F1]Subject to certain criteria, the stock option will vest and become exercisable with respect to 25% of the shares on the first anniversary of the grant date, and the remainder will vest in equal quarterly installments over the subsequent three years.
  • [F2]Each restricted stock unit represents a contingent right to receive one share of MNTA common stock.
  • [F3]Subject to certain criteria, the restricted stock units will vest with respect to 25% of the shares on the first anniversary of the grant date, and the remainder will vest in equal quarterly installments over the subsequent three years.

Documents

1 file
  • 4
    edgar.xmlPrimary

    FORM 4 -